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Objectives: Delays in the diagnosis and detection of bipolar disorder can lead to adverse 
consequences, including improper treatment and increased suicide risk. The Mood 
Spectrum Self‐Report Measure (MOODS‐SR) was designed to capture the full spectrum 
of lifetime mood symptomology with factor scores for depression and mania symptom 
constellations. The utility of the MOODS‐SR as a tool to investigate homogeneous sub‐
groups was examined, with particular focus on a possible bipolar risk subgroup. Moreover, 
potential patterns of differences in MOODS‐SR subtypes were probed using cognitive 
vulnerabilities, neuropsychological functioning, and ventral striatum connectivity.
Methods: K‐mean cluster analysis based on factor scores of MOODS‐SR was used to 
determine homogeneous subgroupings within a healthy and remitted depressed 
young adult sample (N = 86). Between‐group comparisons (based on cluster sub‐
groupings) were conducted on measures of cognitive vulnerabilities, neuropsycho‐
logical functioning, and ventral striatum rs‐fMRI connectivity.
Results: Three groups of participants were identified: one with minimal symptomol‐
ogy, one with moderate primarily depressive symptomology, and one with more se‐
vere manic and depressive symptomology. Differences in impulsivity, neuroticism, 
conscientiousness, facial perception accuracy, and rs‐fMRI connectivity exist be‐
tween moderate and severe groups.
Conclusions: Within a sample of people with and without depression histories, a se‐
vere subgroup was identified with potentially increased risk of developing bipolar 
disorder through use of the MOODS‐SR. This small subgroup had higher levels of 
lifetime depression and mania symptoms. Additionally, differences in traits, affective 
processing, and connectivity exist between those with a more prototypic unipolar 
subgrouping and those with potential risk for developing bipolar disorder.
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1  | INTRODUC TION
Major depressive disorder (MDD) is diagnosed as a separate illness 
from bipolar disorder (BD), yet the behavioral, clinical, performance, 
genetic, and neuroimaging differences between these groups have 
been limited to modest. Indeed, both MDD and BD share major de‐
pressive episodes, one reason why it is not surprising that there are 
overlapping traits in the literature.1‐4 Furthermore, any measure‐
ment that yields a single score for MDD likely misrepresents the het‐
erogeneity of the disorder,5 and does not necessarily rule out bipolar 
spectrum symptoms. Furthermore, early in the course of the illness, 
a substantial minority of those presenting with MDD will later be 
diagnosed with BD.6,7
It is well understood that BD is often missed in screening batter‐
ies for those presenting with mood spectrum pathology and initial 
evaluations for major depressive disorder.8 For example, BD is often 
incorrectly diagnosed and not treated until 10‐20 years after onset, 
usually about 14 years.9 This underdiagnosis of hypomania and mania 
often leads to poorer prognosis due to delay in start of treatment, 
greater disruptions in the life course, adverse life events related to 
untreated manias, and increased risk for suicide.8,10 Difficulties in 
the diagnosis of BD can stem from many sources. Lack of subjective 
distress during hypomanic and manic episodes, and “normalization” 
of some risky behaviors associated with mania during young adult‐
hood (eg, sleep deprivation, substance abuse, sexual experimenta‐
tion)11,12 can contribute to under or delayed diagnosis. Therefore, 
mania is a substantial, poorly perceived risk in the late adolescent 
and young adult period for those with a history of MDD. Faster and 
more accurate diagnosis is a current area of need for this age period.
A number of different methods have been employed to increase 
specificity in assessment tools for MDD and BD (eg, defining more ho‐
mogeneous groups by psychomotor disturbance levels or anxiety).13,14 
These methods have demonstrated some success—for example, de‐
pressed individuals with lower reward responsiveness and higher an‐
hedonia are more likely to have difficulty pursuing simple rewards7 and 
those with melancholic subtype depression tend to have more psycho‐
motor slowing and set‐shifting difficulty.15 More recently, large studies 
using RDoC approaches with dimensional strategies have been able to 
define subcategories: of mood disorders; one through use of Go/No‐
Go responding and another using event‐related potentials.16,17
A combined dimensional and lifespan approach to mood dis‐
orders may aid in more accurate diagnoses by collecting more 
detailed information about prior episodes and periods of relative 
wellness. For example, spectrum models take into account that de‐
pression symptoms can be elevated repeatedly at various points 
over the lifespan or even that certain symptoms never occur at all, 
an idea not accounted for in binary categories of current or recent 
diagnosis.18 Moreover, some symptom patterns may not always be 
present at the point of assessment, yet may be pathognomonic. 
For example, severe anhedonia may only be present in one of 
many prior episodes and would not be specified within a current or 
most recent past diagnosis. Assessing the full spectrum of symp‐
toms across the lifespan may aid in early detection and diagnosis. 
One way to measure the full spectrum of symptoms involved in 
mood disorders is to assess factors of depressive and manic symp‐
toms over the lifetime, including prodromal and subthreshold 
behavioral manifestations, such as through the Mood Spectrum 
Self‐Report Measure (MOODS‐SR).19 Utilizing exploratory factor 
analysis, Cassano and colleagues18 identified six factors related to 
lifetime depression symptoms, including depressive mood (and an‐
hedonia), psychomotor retardation, suicidality, and neurovegeta‐
tive symptoms. In a separate report with patients diagnosed with 
BD, classical exploratory factor analysis revealed factors related 
to mania, including psychomotor activation, creativity (eg, artis‐
tic creativity and sensitivity), mixed instability (eg, sexual promis‐
cuity, alcohol‐related mood change and irritability, and changing 
jobs, residencies, friends, and hobbies), inflated self‐esteem, and 
wastefulness or recklessness (eg, spending more money than one 
can afford, risk‐taking behavior).8
Different lifetime subtypes of mood pathology might have dif‐
ferent biomarkers, cognitive biases, affective traits, and personality 
traits as correlates. For example, higher rumination and impulsivity 
put individuals at even higher risk for developing BD compared to 
developing MDD only.20,21 Neuropsychological batteries and neuro‐
imaging tools might also detect discrepancies in functioning and may 
offer pathophysiological correlates, thus could be a useful way to 
distinguish between subgroups. Specific deficits in neuropsycholog‐
ical functioning are hallmarks of MDD and BD even when the indi‐
vidual is currently well,22,23 although there appears to be substantial 
overlap in these cognitive markers. Differences in these measure‐
ments may be useful to delineate and characterize different mood 
disorder groupings, or better understand the neurobiology that is 
affected in different subgroups.
Indeed, disruption in the functional circuits in the brain, particu‐
larly those supporting emotion processing, emotion regulation, and 
reward processing, have been observed in those with BD.24 One par‐
ticular region of interest in these functional circuits, and particularly 
within resting‐state functional connectivity analyses, has been the 
ventral striatum, involved in reward processing, anhedonia, and be‐
havioral activation. The VS regions, and these related constructs, are 
all potential sources of difference between MDD and BD. In partic‐
ular, this region has shown differences in function and structure in 
those with BD and those at risk for the development of BD.6 A recent 
review has noted increased volume, decreased gray matter in those at 
risk, and increased activity at rest in the ventral striatum.7 Disrupted 
connectivity between the VS and other regions of the brain may rep‐
resent an early neural marker of BD.6 Abnormalities and disruptions 
to this region may correspond to the onset and risk for developing BD.
In the present study, the goal is to identify subtypes of MDD, 
particularly subtypes that are at‐risk for developing BD. We hy‐
pothesize that different subgroups based on mood symptoms of 
this young adult sample can be defined using cluster‐analysis. We 
also expect that these subgroups would display different cognitive 
vulnerabilities, neuropsychological functioning, and neural connec‐
tivity related to the ventral striatum, particularly as it hones in on 
lifetime hypo/mania vulnerability.
     |  699KLING et aL.
2  | METHODS
Study participants (N = 78) from the ages of 18‐23 were recruited 
from the Chicago, IL and Ann Arbor, MI communities. Age range 
was restricted to young adulthood to better highlight any emerging 
subgroup patterns at an optimal point to minimize variance in de‐
velopment and effects of disease progression. Additionally, this age 
range allows testing the hypotheses that some young adults already 
show subthreshold manic symptomatology, and that the MOODS‐
SR might be useful in identifying those at risk for later diagnosis of 
BD. The present study was a secondary sub‐analysis, and the sample 
was under‐powered to explore the optimal number of disease sub‐
types, and is merely an exploratory illustration. Recruiting currently 
remitted patients with MDD minimized current symptom load, as 
they were not currently meeting threshold for a major depressive 
episode. Diagnoses were made based on DSM‐IV criteria using the 
Diagnostic Interview for Genetic Studies25 after informed consent 
was completed, consistent with the Declaration of Helsinki and ap‐
proved by the Institutional Review Boards of the University of Illinois 
at Chicago, and the University of Michigan at Ann Arbor. Remitted 
major depressive disorder (rMDD) participants met criteria for his‐
tory of MDD and were allowed to have current or past co‐morbid 
anxiety disorders. HCs were excluded for any current or past Axis I 
or Axis II disorder. Participants diagnosed with rMDD typically had 1 
or 2 previous episodes (mode of 1 episode). Diagnosis was confirmed 
with family interview (parent or older sibling) using modified Family 
Interview for Genetic Studies.26 All data reported were collected 
over separate intake, cognitive testing, and fMRI sessions.
2.1 | Mood Spectrum Self‐Report (MOODS‐SR)
The MOODS‐SR has 161 yes or no questions regarding whether the 
participant has experienced various situations now or in the past, 
which are then summed into factors.8,18,19
2.2 | Clinical variables
Clinical variables of interest regarding illness were collected through 
the DIGS, including age of first episode, number of depressive epi‐
sodes, length of longest depressive episode, and Global Assessment 
of Functioning (GAF).25 Family history was ascertained as part of the 
DIGS, adapted FIGS, and Longitudinal Interval Follow‐up Evaluations 
(LIFE), coded for the presence of any mood disorder.
2.3 | Questionnaire Measures
The Ruminative Responses Scale (RRS) is a self‐report measure of 
rumination.27 Two motivational systems were measured by the BIS/
BAS.28 The Barratt Impulsiveness Scale (BIS‐11) is a self‐report meas‐
ure of impulsive behavior and preferences.29 The NEO‐Personality 
Inventory‐Revised (NEO‐PI‐R) was administered to assess five major 
domains of personality: Openness to Experience, Conscientiousness, 
Extraversion, Agreeableness, and Neuroticism.30
2.4 | Neuropsychological measures
Estimated Intelligence Quotient was assessed using the Synonym 
Knowledge Task to determine if subtypes differ in global cogni‐
tive ability.31 The Facial Emotion Perception Test (FEPT) is a test 
of accuracy and speed in identification of facial expressions in‐
cluding accuracy for fear, anger, happy, sad, and neutral faces.32 
The Modified, Titrated Monetary Incentive Delay Task (mMID) is a 
simple, contingent reward sensitivity task dependent on respond‐
ing to a rapid response window. The task is titrated based on the 
participant’s accuracy and speed to optimize performance to per‐
ceived difficulty ratios.33 Money earned during the last two runs 
was used as the dependent variable. The Parametric Go/No‐Go 
Task captures sustained attention, inhibitory control, and process‐
ing speed to target cues.32,34 Reaction time and percent correct 
inhibition were assessed for both 2 and 3 target trials. Controlled 
Oral Word Association Test (COWA) provides a measure of verbal 
fluency to confrontation based on cues of the first consonant in 
words.35 The Wisconsin Card Sorting Test provides a measure of 
executive functioning, including inferential problem solving using 
error percentiles.36 Trail Making A/B and C/D were also admin‐
istered, capturing visual speed and switching, respectively.37 The 
Purdue Pegboard provides a measure of bimanual dexterity.
2.5 | fMRI acquisition
The University of Michigan scan consisted of an eyes‐open resting 
state scan acquired over 8 minutes using a 3.0 T GE Signa scanner 
(Milwaukee, WI). We used T2*‐weighted single shot reverse spiral 
sequences with the following parameters: 90 degree flip, field‐of‐
view 20, matrix size = 64 × 64, slice thickness = 4 mm, 30 ms echo 
time, 29 slices. At the University of Illinois, we collected eyes‐open, 
eight minute resting scans using a 3.0 T GE Discovery scanner 
(Milwaukee, WI), using parallel imaging with ASSET and T2* gradi‐
ent‐echo axial EPI. We used the following parameters: 90 degree 
flip, field‐of‐view = 22 × 22 cm, matrix size = 64 × 64, slice thick‐
ness = 3 mm (0 mm gap), 22.2 ms echo time, 44 slices. At both loca‐
tions, high‐resolution anatomic T1 scans were obtained for spatial 
normalization. Motion was minimized using foam pads, and/or cross 
on the display, and participants were told the importance of staying 
still. Additionally, a visual tracking line was used at the University 
of Illinois. For both sites, TRs of 2000 ms were used, with a total of 
240 TRs.
2.6 | fMRI preprocessing
We took several steps to reduce effects of noise and artifact. Slice 
time correction was completed in SPM8 (https://www.fil.ion.ucl.
ac.uk/spm/doc/), and we applied motion detection and correction 
algorithms using FSL (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/). We 
used coregistration of structural images to functional images. Next, 
we used spatial normalization of the coregistered T1‐spgr to the 
Montreal Neurological Institute (MNI) template. The normalization 
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matrix was applied to the slice‐time‐corrected, time series data. The 
result, normalized T2* timeseries data, was spatially smoothed with 
a 5‐mm Gaussian kernel producing T2* images with isotropic voxels, 
2 mm on a side.
2.7 | fMRI cross‐correlation analysis
Time series data were detrended and mean‐centered. Additionally, 
physiologic correction was performed by regressing out white 
matter and cerebral spinal fluid signals.38 Motion parameters were 
regressed out.39 Global signal was not regressed due to collinear‐
ity violations with gray matter signal, challenging mis‐estimates of 
anticorrelations,40 and nonlinear impact on distance‐micromove‐
ment relationships.39 Time‐series were band‐pass filtered over 
0.01‐0.10 Hz. Seeds were derived based on previous literature ex‐
amining resting state connectivity of the ventral striatum.41 The 
following Montreal Neurologic Institute (MNI) coordinates were 
used based on prior work: right superior ventral striatum (RVSs; 10, 
TA B L E  1   Demographics and MOOD‐SR clusters
Min (N = 31) Mod (N = 34) Sev (N = 13) Statistical analysis
M (SD) M (SD) M (SD) F P‐value
Demographics
Males (N) 9 9 5 0.66 0.72
rMDD (N) 3 34 13 66.23 <0.001
Race (N Caucasian) 21 18 8 15.04 0.52
Age 20.71 (1.62) 21.26 (1.54) 20.92 (1.75) 0.978 0.38
Education 14.61 (1.45) 14.71 (1.36) 13.85 (1.52) 1.81 0.17
Verbal IQ 104.45 (9.57) 106.73 (8.48) 101.62 (10.82) 1.47 0.24
Longest MDE 8.00 (0.00) 27.39 (30.33) 26.5 (36.71) 0.18 0.84
GAF at Intake 91.52 (4.42) 82.54 (8.74) 77.73 (11.48) 17.13 <0.001a
Age of first episode 17.5 (2.12) 16.47 (4.33) 15.75 (4.18) 0.20 0.82
Number of MDE 0.15 (0.38) 1.71 (1.29) 2.92 (2.81) 9.43 <0.001b
MOOD‐SR clusters
Depression factors
Depressed mood 1.87 (2.09) 16.29 (2.8) 16.92 (4.96) 217.95 <0.001b
Psychomotor retardation 1.13 (1.73) 8.53 (3.58) 11.60 (1.86) 92.14 <0.001b,c
Suicidality 0.26 (0.68) 2.24 (1.76) 2.38 (1.98) 17.54 <0.001b
Drug/illness related depression 0.00 (0.00) 0.56 (0.89) 1.23 (1.09) 13.46 <0.001b,c
Psychotic features 0.48 (0.96) 2.15 (1.23) 3.46 (1.13) 37.4 <0.001b,c
Neurovegetative symptoms 1.35(1.72) 5.15 (2.28) 7.77 (1.88) 55.06 <0.001b,c
Mania factors
Psychomotor activation 1.06 (1.61) 2.97 (2.46) 9.54 (2.5) 70.78 <0.001b,c
Creativity 2.2 (2.23) 5.29 (2.46) 8.69 (1.25) 42.27 <0.001b,c
Mixed instability 0.42 (0.62) 1.18 (0.83) 2.85 (1.99) 24.63 <0.001b,c
Sociability/extraversion 2.19 (1.94) 2.26 (1.8) 4.15(1.63) 5.99 0.004d
Spirituality/mysticism/
psychoticism
0.23 (0.76) 0.47 (1.13) 1.77 (1.64) 9.22 <0.001d
Mixed irritability 0.46 (0.77) 1.91 (1.22) 4.38 (1.5) 57.21 <0.001b,c
Inflated self‐esteem 0.16 (0.45) 0.91 (1.11) 3.23 (1.59) 42.13 <0.001b,c
Euphoria 0.81 (1.08) 1.89 (1.51) 4.08 (1.04) 29.97 <0.001b,c
Wastefulness/recklessness 0.74 (1.09) 0.85 (1.10) 2.46 (0.88) 13.22 <0.001d
Min, Minimal; Mod, Moderate (Unipolar); Sev, Severe; M, Mean; SD, Standard Deviation; IQ, Intelligence Quotient; MDE, Major Depressive Episode in 
weeks; GAF, Global Assessment of Functioning; rMDD, remitted Major Depression.
aMin > Mod, Sev. 
bMod, Sev > Min. 
cSev > Mod. 
dSev > Min, Mod. 
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15,	0),	 right	 inferior	ventral	 striatum	 (RVSi;	9,	9,	−8),	 left	 superior	
ventral	striatum	(LVSs;	−10,	15,	0),	and	left	inferior	ventral	striatum	
(LVSi;	−10,	15,	0).	The	VSi	is	what	is	traditionally	considered	nucleus	
accumbens in humans, and the VSs is ventral caudate, and we used 
these pre‐existing foci to enable comparisons with prior studies.41
2.8 | Statistical analyses
2.8.1 | K‐means cluster analysis to determine 
homogeneous subsets
Utilizing the factors developed by Cassano and colleagues,8,18 
nine mania and six depression factors from the MOODS‐SR were 
entered into a k‐cluster analysis to divide participants, with an op‐
timal solution of three clusters based on sample size and AIC cri‐
teria (AIC = 668.74, chosen to maintain statistical power while 
allowing investigation into more homogeneous subgroupings. The 
two‐ (AIC = 687.56) and four‐ (AIC = 676.22) cluster solutions were 
equivalent in silhouette measure of cohesion and separation (.4 for 
all 3 solutions). Moroever, a two‐cluster solution recapitulated the 
case‐control group membership, making it a less ideal solution. The 
four‐cluster solution had one cell which was too small (n = 6) for 
subsequent comparisons, rendering the three‐cluster solution op‐
timal for the hypotheses put forth. The three‐cluster solution was 
derived from differences in factor scores from both depression and 
mania subscales of the MOODS‐SR. Based on clinical characteristics 
and the scores on the MOODS‐SR factors, the k‐clusters were then 
labeled Minimal (Min), Moderate (Mod), and Severe (Sev; Table 1).
2.8.2 | Cluster group comparisons
A series of ANOVAs were computed between the three cluster 
groups. For questionnaire measures, and neuropsychological 
tests, significant ANOVAS were followed by post hoc tests 
with Bonferroni corrections to determine specific differ‐
ences between patient clusters. For rs‐fMRI, a threshold of 
P < 0.005 and cluster extent of 57 voxels was used (P <0.01 
corrected for each model) based on the updated 2016 version 
of 3dClustsim.42 Data from significant areas of group differ‐
ences in connectivity were extracted using Marsbar (https://




The Min cluster consisted of a mixture of HC (N = 28) and rMDD 
(N = 3), while the Mod and Sev clusters consisted only of rMDD 
(N = 34; N = 13, respectively; Table 1). There was a main effect 
of group on all measures of the MOODS‐SR (Table 1). Post hoc 
tests were run to determine pairwise differences. The Min cluster 
was significantly lower than Sev on all factors (P < 0.001). Min was 
significantly lower than Mod on all factors (all P < 0.02) except 
Sociability/Extraversion, Spirituality/Mysticism/Psychoticism, 
and Wastefulness. Sev was higher than Mod on all factors except 
for Depressed Mood and Suicidality (Table 1). Clinically, Min was 
higher in GAF than Mod and Sev (P < 0.001; P < 0.001; Table 1). 
Those in Sev group were numerically, but not significantly more 
likely to have a positive family history of mood disorder (6/12) 
relative to Mod (12/32) and Min (5/27), (X = 4.58 (2), P = 0.11), all 
but one (hx of BD) of whom were positive history of MDD. Among 
rMDD, those without family history were significantly higher 
in Depression (F (1,46) = 4.39, P = 0.04) and Suicidal ideation (F 
(1,46) = 4.90, P = 0.03) factors, but did not differ in any other fac‐
tors (ps > 0.11) (Figure 1).
F I G U R E  1   Example of distribution for a depression and mania factors of the MOOD‐SR Psychomotor Retardation (A) and Psychomotor 
Activation (B) is shown separated by group. There is very little overlap of the Min and Sev groups. Min, Minimal; Mod, Moderate; Sev, Severe 
[Colour figure can be viewed at wileyonlinelibrary.com]
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3.2 | Connectivity to RVSs
Results are reported in Supplemental Table S1 and Figure 2. The 
areas of connectivity that differed amongst the MOODS‐SR groups 
were in regions posited to be part of the cognitive control network—
middle and inferior frontal gyri, precuneus, and anterior cingulate 
cortex. Post hoc Bonferroni tests were run to determine pairwise 
differences. Connectivity was higher in Mod vs Sev in middle and 
inferior frontal gyri. Connectivity was higher in Min, Mod vs Sev for 
anterior cingulate cortex. It was lower in the precuneus in Min vs 
Mod, and Sev.
3.3 | Connectivity to LVSs
Results are reported in Supplemental Table S2 and Figure 3. 
There is a main effect of group in a large number of networks, 
including cognitive control, default mode, and secondary visual 
regions. Post hoc Bonferroni tests were run to determine pair‐
wise differences. Mod was higher than Sev in the middle frontal 
gyrus. Mod showed significantly higher connectivity than Min 
in the inferior frontal gyrus, supramarginal gyrus, and cuneus. 
For the supramarginal gyrus, posterior cingulate, and caudate, 
Mod was significantly higher than Min and Sev. Connectivity 
in the lingual gyrus was significantly higher in Sev vs Min and 
Mod. For the fusiform gyrus, Sev was significantly higher than 
Min. In the anterior cingulate gyrus and for the other cluster in 
the posterior cingulate gyrus, Min was significantly lower than 
Mod and Sev.
F I G U R E  2   Differences in connectivity to RVSs seed. Regions 
of significant differences between groups are displayed in Panel 
A. Mean connectivity for each group is illustrated for each cluster 
in Panel B. Error bars represent 1 standard error. Significant 
relationships between clusters are denoted by asterisks.: 
**=P < 0.05 between Min and Sev, ***=P < 0.05 between Mod and 
Sev, MFG, middle frontal gyrus; IFG, inferior frontal gyrus; ACC, 










F I G U R E  3   Differences in connectivity 
to LVSs seed. Regions of significant 
differences between groups are displayed 
in Panel A. Mean connectivity for each 
group is illustrated for each cluster in 
Panel B. Error bars represent 1 standard 
error. Significant relationships between 
clusters are denoted by asterisks.: 
*=P < 0.05 between Min and Mod 
**=P < 0.05 between Min and Sev, 
***=P < 0.05 between Mod and Sev, 
MFG, middle frontal gyrus; IFG, inferior 
frontal gyrus; ACC, anterior cingulate; 
SMG, supramarginal gyrus; PCC, posterior 
cingulate cortex; LING, lingual gyrus; FFG, 
fusiform gyrus; CAU, caudate [Colour 
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3.4 | Connectivity to RVSi
Results are reported in Supplemental Table S3 and Figure 4. 
There was a main effect of group for the precuneus and the 
vermis. Post hoc Bonferroni tests were run to determine 
pairwise differences. In the precuneus, Sev was significantly 
higher than Min and Mod. Connectivity with the vermis was 
significantly higher in Sev vs Min and Mod.
3.5 | Connectivity to LVSi
There were no significant main effect of group observed for LVSi.
3.6 | Questionnaire measures
There was a significant main effect of group on the RRS, BIS‐11 Total, 
BAS Total, Neuroticism, Extraversion, Openness, and Consciousness 
(Table 2). Post hoc Bonferroni tests were run to determine pairwise 
differences. On the RRS, Min was lower than Mod and Sev. Mod was 
lower than Sev on BIS‐11. Min was lower than Mod for the BAS total 
only. Min and Mod were significantly lower than Sev on Neuroticism, 
and higher in Conscientiousness.Min was higher in extraversion than 
Mod and Sev. Sev was significantly higher in Openness relative to Mod.
3.7 | Neuropsychological variables
There was a significant main effect of group on fear and anger ac‐
curacy (Table 3). Post hoc Bonferroni tests were run to determine 
pairwise differences. Sev performed significantly better on fear ac‐
curacy than Min and Mod, and better in anger accuracy than Min. All 
other neuropsychological tests did not show a statistically signifi‐
cant main effect of group.
4  | DISCUSSION
The present study was conducted to ascertain whether lifetime 
symptoms of depression and mania might aid in detecting more 
F I G U R E  4   Differences in connectivity to RVSi seed. Regions of 
significant differences between groups are displayed in Panel A. 
Mean signal for each group is illustrated for each cluster in Panel 
B. Error bars represent 1 standard error. **=P < 0.05 between Min 






TA B L E  2   Cluster differences in questionnaire measures
Min Mod Sev Statistical analysis
M (SD) M (SD) M (SD) F P‐value
RRS total 30.4 (8.82) 46.90 (16.13) 51.67 (14.16) 16.61 <0.001a
BIS‐11 total 53.23 (10.38) 49.00 (11.00) 60.08 (8.47) 5.47 0.01b
BIS total 18.97 (2.82) 20.35 (3.46) 18.77 (3.30) 1.98 0.15
BAS total 36.90 (11.47) 43.74 (4.04) 41.85 (9.93) 5.14 0.01c
NEO‐PI neuroticism 71.69 (17.88) 81.97 (23.52) 107.15 (13.65) 12.04 <0.001d
NEO‐PI extraversion 128.86 (18.45) 113.21 (20.81) 109.23 (119.36) 6.440 0.003e
NEO‐PI openness 121.03 (17.15) 128.03 (16.16) 139.31 (14.56) 5.923 0.004b
NEO‐PI agreeableness 123.24 (14.22) 123.09 (15.19) 115.31 (12.93) 1.830 0.17
NEO‐PI conscientiousness 125.83 (16.89) 123.82 (19.75) 111.62 (15.81) 4.268 0.02e
Min, Minimal; Mod, Moderate (Unipolar); Sev, Severe; M, Mean; SD, Standard Deviation; RRS, Ruminative Responses Scale; BIS‐11, Barrett Impulsiveness 
Scale; BIS, Behavioral Inhibition System; BAS, Behavioral Activation System.
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homogeneous subgroups of MDD. This study yielded three dif‐
ferent cluster groups based on lifetime symptoms within an oth‐
erwise homogeneous sample of remitted MDD young adults and 
age matched healthy comparison adults. We were able to detect a 
group with minimal mood symptomology (primarily HCs and at a 
lower risk of developing mood pathology), a group with moderate 
and primarily unipolar symptomology (Mod), and a group that was 
more severe in both elevated manic and depressive symptomology 
(Sev). We were able to illustrate differences that delineated the Mod 
and Sev clusters, including differences in connectivity with the VS, 
facial perception performance, self‐reported impulsivity, and self‐re‐
ported extraversion and conscientiousness. This appears to be the 
first study to examine the MOODS‐SR in a remitted sample, and to 
highlight that a bipolar risk subgroup could potentially be defined 
with MOODS‐SR early in the course of MDD.
There was a small group of individuals currently remitted for 
MDD who endorsed significantly higher lifetime mania symp‐
toms, although not clinically elevated to the point that it would 
be captured in diagnostic interviews. This finding is consistent 
with the presence of many prodromal symptoms before the de‐
velopment and awareness of BD, including mood lability and ela‐
tion, swings or cyclothymic features, racing thoughts, irritability, 
and psychomotor activation, (many of the mania factors in the 
MOODS‐SR).43,44 This group also endorsed more severe lifetime 
depressive symptoms in four factors. Sev may represent a dis‐








21.9 (7.93) 22.50 (7.17) 22.00 (6.53) 0.60 0.94
B/D (switching) in 
secs




10.47 (1.72) 10.54 (1.88) 9.47 (1.47) 1.89 0.16
Controlled oral word




53.16 (26.84) 59.15 (25.97) 60.31 (36.39) 0.47 0.63
Modified titrated monetary incentive delay
$ (Reward 
processing)
38.01 (11.75) 36.42 (11.06) 33.8 (13.61) 0.48 0.62
Facial emotion perception
Fear accuracy 0.81 (0.11) 0.81 (0.13) 0.93 (0.07) 4.15 0.02a
Anger accuracy 0.66 (0.22) 0.76 (0.19) 0.91 (0.11) 6.56 0.003b
Happy accuracy 0.96 (0.08) 0.97 (0.06) 0.96 (0.06) 0.42 0.66
Sad accuracy 0.77 (0.19) 0.84 (0.14) 0.80 (0.15) 1.27 0.29
Neutral accuracy 0.77 (0.22) 0.68 (0.2) 0.72 (0.08) 1.55 0.22
Parametric Go/No‐go
2 Target RT 424.51 (37.22) 423.15 (46.31) 436.06 (66.38) 0.38 0.69
2 Target inhibition 0.77 (0.19) 0.77 (0.18) 0.69 (0.20) 0.99 0.38
3 Target RT 498.89 (51.99) 491.66 (53.22) 509.69 (52.93) 0.57 0.57
3 Target inhibition 0.58 (0.19) 0.66 (0.19) 0.54 (0.16) 2.12 0.13
Bonferroni corrections were used. All significant P‐values are shown.
Min, Minimal; Mod, Moderate; Sev, Severe; M, Mean; SD, Standard Deviation; sec, seconds; COWA, 
Controlled Oral Word Association Test; WSCT, Wisconsin Card Sorting Test; mtMID, Modified 
Monetary Incentive Delay; FEPT, Facial Emotion Perception Task; PGNG, Parametric Go/No‐Go; RT, 
Reaction Time.
aSev > Min, Mod. 
bSev > Min. 
TA B L E  3   Cluster differences in 
neuropsychological measures
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may never go on to develop BD. Alternatively, this group’s eleva‐
tion in lifetime mania symptoms may put them at risk to develop 
BD, or more likely reflects a subtype of MDD with elements of 
BD symptomatology at the subthreshold level.45‐47 We add that 
the Sev group was nominally more likely to have a positive fam‐
ily history of MDD (50%), relative to the Mod and Min groups. 
Future work can determine whether family history may be linked 
to more mixed lifetime symptoms and different connectivity, 
neuropsychological functioning, and trait factors. As all but one 
of these individuals with positive family history was for MDD 
and not for BD, family history was not likely to be definitive.
The Moderate group defined by cluster analysis presented as 
more moderate in lifetime symptomatology, and endorsed more un‐
ipolar symptoms relative to bipolar symptoms. The key difference 
between this group and the more severe group was endorsement of 
manic symptoms. They also differed on six of the eight depressive 
symptom factor scores, with Sev higher than Mod.
Several facets stand out as important distinguishing constructs 
between the Sev group and the other two clusters of rMDD. Sev 
showed higher trait impulsivity than Mod and Min on reported im‐
pulsivity. Higher trait impulsivity tends to represent a marker for de‐
veloping BD, although it has also been linked to MDD and ADHD. 
Both higher neuroticism and lower conscientiousness distinguished 
Sev from the other clusters in this study, which may be a potential 
subtyping feature for risk for BD, consistent with the literature in 
BD.48 Further research must be done to determine if impulsivity, 
trait neuroticism, and trait low conscientious are a useful way to dis‐
criminate those who are at increased risk to develop BD from those 
who are more likely to remain unipolar.
Surprisingly, the Sev group was better at correctly identifying 
fear and anger facial expressions. One meta‐analysis has found less 
impairment for identifying emotions in faces in those with BD than 
those with schizophrenia and with MDD,49 while another found the 
degree of impairment to be comparable between BD and MDD.50 
Prior studies of those with BD may illustrate impaired emotion pro‐
cessing due to active symptoms or disease scar.50 This study’s emo‐
tion processing differences cannot be accounted for by differences 
in attention, executive function, visual memory or verbal memory. 
The superior detection of negative emotions in bipolar risk vs more 
unipolar rMDD individuals may perhaps be useful in distinguishing 
the two subgroups and may be useful at detecting subsyndromal 
manic features early in the course of illness. In other words, individ‐
uals with MDD who do not possess impairment in facial perception 
may represent a special group to follow as they may present with 
mania symptomatology.
Across studies, reduced connectivity has been found in pre‐
frontal and limbic brain regions for BD and MDD.51,52 Connectivity 
studies have supported a model positing dysfunction of subcorti‐
cal‐prefrontal networks and limbic regions in BD, where disruption 
of mood may be caused by reduced prefrontal modulation of sub‐
cortical and medial temporal structures within the anterior limbic 
system.52 Within the current study, connectivity analyses revealed 
disrupted connectivity with the VS in the Sev group, which could 
be useful to delineate those at risk for developing BD vs those who 
show primarily unipolar symptomology. Compared to Mod, Sev 
had reduced connectivity between the RVSs and several anterior 
cognitive control regions, perhaps highlighting diminished regula‐
tory capacity for approach behaviors. In contrast, for the left VSs 
a different pattern was evident of elevated connectivity for Mod 
relative to Sev and Min in a widespread set of regions including 
cognitive control regions, and emotion processing. A few regions 
showed elevation in Sev relative to Min and Mod, including second‐
ary visual processing regions, including those for facial emotion. In 
the right VSi, there was increased connectivity in Sev with the pre‐
cuneus, and decreased connectivity with the vermis compared to 
Mod. These connectivity disruptions may represent early and sen‐
sitive risk markers, particularly for the left VSs, for those at high‐risk 
for developing BD.
Developing homogeneous subgroupings can aid in better diag‐
nosis, and potentially, better treatment for the mood disorder spec‐
trum. While antidepressants are highly effective for those with solely 
depressive symptomatology, up to 50% of people who are diagnosed 
with unipolar MDD are resistant to antidepressants, and have sub‐
threshold or threshold manic symptoms.53 Depending on the length 
of the observation period, 15%‐30% of people who were previously 
diagnosed as unipolar progress to BD.54 Thus, not only could use of 
the MOODS‐SR in this age range lead to designation of individuals 
in "high risk" categories, it may also lead to earlier treatment and 
improved prevention efforts. Indeed, there may be increased speci‐
ficity in the nature and types of treatments that could work for these 
subgroups. Identification of neural, neuropsychological, or person‐
ality features that aid in risk determination could lead to earlier and 
more effective treatment.
This study has a few limitations to cover. A strength of the study 
was that multiple methods were used to validate subgroups; how‐
ever, future studies will be needed to further validate links to BD by 
recruiting groups with elevated lifetime mania symptoms with and 
without a history of BD. Additionally, these studies would benefit 
from larger sample sizes to increase power, as the present study was 
a secondary data analysis with a sample of convenience. The sam‐
ple size was not large enough to form additional cluster subgroups 
(to evaluate what might be an optimal cluster number) because suf‐
ficient power would have been lost to determine trait differences 
between smaller cluster groups. The three‐cluster solution was only 
marginally lower in AIC relative to the two‐ and four‐cluster solu‐
tions and was identical in the silhouette measure. A larger sample 
size would be beneficial in determining further homogeneous sub‐
groupings/clusters in those with mood disorders. In addition, some 
measures expected to vary across mood clusters did not show signif‐
icant differences between our clusters, such as inhibition or biman‐
ual dexterity. This may have been due to a focus on lifetime mood 
symptomology in a currently remitted sample, which is more likely to 
highlight trait rather than state differences. Finally, we were unable 
to prospectively follow this sample to determine final diagnostic out‐
comes, and thus empirically testing conversion from MDD diagnosis 
to BD remains an active area of research. Alternatively, comparison 
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to a group with diagnosis of BD could have clarified whether the 
BD and Sev groups were similar on a number of neuropsychological, 
trait, and brain imaging features. Future studies will need to deter‐
mine the course of illness in such groups, and to determine if these 
groups are a risk group for BD or if they represent a subtype of MDD 
with subthreshold mania symptomology.
In conclusion, the MOOD‐SR is a useful tool to reduce homo‐
geneity within young, remitted MDD samples. It also may be a use‐
ful tool to identify those at risk for developing BD, even in those 
whose illness clinically and historically presents as unipolar. There 
may be a subgroup of people with depression histories who have 
been improperly diagnosed or are at risk of developing more severe 
pathology in the future. It is more likely that there is an MDD sub‐
group with some subthreshold manic symptomatology, and these in‐
dividuals may show a different clinical course with different optimal 
treatments.
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